(Q28341602)
Statements
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group (English)
0 references
December 1989
0 references
80
0 references
6
0 references
1557-70
0 references